Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond

被引:20
|
作者
Zhu, Yalan [1 ]
Xu, Lingling [2 ]
Kang, Yong [2 ]
Cheng, Qinzhen [1 ]
He, Yiling [1 ]
Ji, Xiaoyuan [2 ,3 ]
机构
[1] Jinhua Municipal Cent Hosp, Dept Pharm, Jinhua 321000, Zhejiang, Peoples R China
[2] Tianjin Univ, Acad Med Engn & Translat Med, Med Coll, Tianjin 300072, Peoples R China
[3] Linyi Univ, Med Coll, Linyi 276000, Peoples R China
关键词
Platelet; Platelet-derived drug delivery systems; Targeted delivery; Disease treatment; EXTRACELLULAR VESICLES; TARGETED DELIVERY; STEM-CELLS; NANOPARTICLES; MICROPARTICLES; INFLAMMATION; MICROVESICLES; NANOMEDICINE; CYTOTOXICITY; NANOCARRIERS;
D O I
10.1016/j.biomaterials.2024.122478
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Platelets play a critical role as circulating cells in the human body and contribute to essential physiological processes such as blood clotting, hemostasis, vascular repair, and thrombus formation. Currently, platelets are extensively employed in the development of innovative biomimetic drug delivery systems, offering significant enhancements in circulation time, biocompatibility, and targeted delivery efficiency compared to conventional drug delivery approaches. Leveraging the unique physiological functions of platelets, these platelet-derived drug delivery systems (DDSs) hold great promise for the treatment of diverse diseases, including cancer, cardiovascular diseases, infectious diseases, wound healing and other diseases. This review primarily focuses on the design and characteristics of existing platelet-derived DDSs, including their preparation and characterization methods. Furthermore, this review comprehensively outlines the applications of these materials across various diseases, offering a holistic understanding of their therapeutic potential. This study aimed to provide a comprehensive overview of the potential value of these materials in clinical treatment, serving as a valuable reference for the advancement of novel platelet-derived DDSs and their broader utilization in the field of disease treatment.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Bioresponsive drug delivery systems for the treatment of inflammatory diseases
    Dou, Yin
    Li, Chenwen
    Li, Lanlan
    Guo, Jiawei
    Zhang, Jianxiang
    JOURNAL OF CONTROLLED RELEASE, 2020, 327 : 641 - 666
  • [22] Drug delivery system to control infectious diseases
    Shoji, Y
    Shimada, J
    Mizushima, Y
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (06) : 455 - 465
  • [23] Plant-Derived Biomolecules and Drug Delivery Systems in the Treatment of Liver and Kidney Diseases
    Hermenean, Anca
    Smeu, Claudia
    Gharbia, Sami
    Krizbai, Istvan A.
    Ardelean, Aurel
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (35) : 5415 - 5441
  • [24] Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases
    Singh, Vanshikha
    Eljaaly, Khalid
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 75
  • [25] Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases
    Douafer, Hana
    Andrieu, Veronique
    Brunel, Jean Michel
    JOURNAL OF CONTROLLED RELEASE, 2020, 325 : 276 - 292
  • [26] Treatment of infectious diseases and drug resistance
    St Georgiev, V
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (24) : 3073 - 3075
  • [27] Nanotechnology-based drug delivery systems for curcumin and its derivatives in the treatment of cardiovascular diseases
    Sun, Qing
    Lv, Mei
    Li, Yuhui
    JOURNAL OF FUNCTIONAL FOODS, 2024, 122
  • [28] Predatory Bacteria in the Treatment of Infectious Diseases and Beyond
    Alexakis, Konstantinos
    Baliou, Stella
    Ioannou, Petros
    INFECTIOUS DISEASE REPORTS, 2024, 16 (04) : 684 - 698
  • [30] Call for Papers: Drug Resistance in Infectious Diseases and Beyond
    Schiffer, Celia A.
    Hazuda, Daria J.
    ACS INFECTIOUS DISEASES, 2022, 8 (04): : 665 - 666